Our tailored audit will help you identify your strengths and weaknesses and generate individual solutions to achieve the required standards. The number of days required will depend on the size of the organisation and can range between one and three days.
This will involve a former Accountable Officer and a Pharmacist spending reviewing protocols and procedures and preparing a final report which will be delivered both verbally and in hard copy to the organisation concerned.
The collaborative inspection is designed to explore how an organisation manages controlled drugs by auditing all elements governed by the Controlled Drugs Accountable Officer (CDAO).
The aim is to reduce organisational risk caused by inappropriate use of CDs by ensuring adherence to internal policies and procedures whilst being aligned to National legislation.
Our audit team, who have a wealth of knowledge in managing and handling controlled drugs combined with critical incident investigation experience carry, out the visit. The audit team will immerse itself into your organisation to fully understand the entire journey of controlled drugs from delivery to patient.
By auditing each department, our team are able to work collaboratively with your team to identify areas of risk, along with assessing adherence to your standard operating procedures. To improve the management of controlled drugs, we design solutions to reduce identified risks, whilst being respectful of the need to deliver patient care.
This collaborative approach has resulted in operating changes within organisations that have enhanced their safe handling and effective management of controlled drugs.
The inspection concludes with feedback to the CDAO to articulate the observations along with suggested improvements. These are rated in order of severity to identify areas of priority for implementation following the inspection.
